Cargando…
The Fraction Exhaled Nitric Oxide as a Biomarker of Asthma Control
INTRODUCTION AND OBJECTIVE: The main goal of asthma treatment is to achieve and maintain clinical control of the disease. The exhaled fraction nitric oxide (FeNO) level is a biomarker of T-helper cell type 2 (Th2) inflammation of the airways. Our objective was to determine whether the FeNO level can...
Autores principales: | de Abreu, Fernanda Cruvinel, da Silva Júnior, Jose Laerte Rodrigues, Rabahi, Marcelo Fouad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357290/ https://www.ncbi.nlm.nih.gov/pubmed/30728712 http://dx.doi.org/10.1177/1177271919826550 |
Ejemplares similares
-
Measurements of fractional exhaled nitric oxide in pediatric asthma
por: Hahn, Youn-Soo
Publicado: (2013) -
Fractional exhaled nitric oxide (FeNo) in different asthma phenotypes
por: Gemicioglu, Bilun, et al.
Publicado: (2014) -
Fractional exhaled nitric oxide (FeNO) measurement in asthma and rhinitis
por: Gevorgyan, Artur, et al.
Publicado: (2013) -
Fractional exhaled nitric oxide (FeNO): the future of asthma care?
por: Wang, Kay, et al.
Publicado: (2023) -
ASSOCIATION BETWEEN FRACTION OF EXHALED NITRIC OXIDE AND SPIROMETRY DATA AND CLINICAL CONTROL OF ASTHMA IN CHILDREN AND ADOLESCENTS
por: Salviano, Luanda Dias da Silva, et al.
Publicado: (2018)